103 related articles for article (PubMed ID: 14111325)
1. DIFFERENT MODES OF ACTION OF TWO ANTIOVULATORY COMPOUNDS.
OVERBEEK GA; DEVISSER J
Acta Endocrinol (Copenh); 1964; 45():SUPPL90:179-90. PubMed ID: 14111325
[No Abstract] [Full Text] [Related]
2. DIFFICULTIES IN DETERMINING THE SITE OF ACTION OF OVULATION INHIBITORS.
OVERBEEK GA; DE VISSER J
Int J Fertil; 1964; 9():177-9. PubMed ID: 14106253
[No Abstract] [Full Text] [Related]
3. [ON THE METHANISM OF THE OVULATION-INHIBITING EFFECT OF ORAL PROGESTAGENS].
SAS M; KOVACS L; NEMETH I; SZONTAGH FE
Endokrinologie; 1964 Feb; 46():58-64. PubMed ID: 14184333
[No Abstract] [Full Text] [Related]
4. ORAL CONTRACEPTION.
MORRIS N
Practitioner; 1965 Apr; 194():478-84. PubMed ID: 14273194
[No Abstract] [Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
6. INFLUENCE OF TWO NONSTEROIDAL ANTIESTROGENS ON VAGINAL OPENING AND PMS-INDUCED OVULATION IN RATS.
COPPOLA JA; PERRINE JW
Endocrinology; 1965 May; 76():865-9. PubMed ID: 14290146
[No Abstract] [Full Text] [Related]
7. [APROPOS OF THE OVULATION-INHIBITING DOSAGE OF ORAL GESTAGENS].
SZONTAGH FE; SAS M
Zentralbl Gynakol; 1964 Mar; 86():410-2. PubMed ID: 14198198
[No Abstract] [Full Text] [Related]
8. [ANTIGONADOTROPHIC ACTION OF 3-DESOXY-17-ALPHA-ETHYNYL-19-NORTESTOSTERONE].
BAGNATI EP; ZAPATA AC; BUR GE; GURUCHARRI CA; COLILLAS OJ
Prensa Med Argent; 1964 Jul; 51():140-2. PubMed ID: 14175982
[No Abstract] [Full Text] [Related]
9. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
[TBL] [Abstract][Full Text] [Related]
10. The role of follicle-stimulating hormone (FSH), in combination with luteinizing hormone (LH), in oestrogen-induced ovulation during the oestrous cycle in the rat.
Plas-Roser S; Hassani M; Aron C
Acta Endocrinol (Copenh); 1977 May; 85(1):151-7. PubMed ID: 577073
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
12. OPTIMUM DOSAGE FOR ESTROGEN-PROGESTOGEN BALANCE TO INHIBIT OVULATION.
JACKSON MC; LINN R
Int J Fertil; 1964; 9():75-86. PubMed ID: 14106271
[No Abstract] [Full Text] [Related]
13. [ON EXPERIENCES WITH A NEW OVULATION-INHIBITING COMBINATION OF LYNESTRENOL AND MESTRANOL].
KOPERA H; IJZEMAN GL
Ther Ggw; 1964 May; 103():657-65. PubMed ID: 14235815
[No Abstract] [Full Text] [Related]
14. Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
Schally AV; Parlow AF; Carter WH; Saito M; Bowers CY; Arimura A
Endocrinology; 1970 Mar; 86(3):530-41. PubMed ID: 4188612
[No Abstract] [Full Text] [Related]
15. THE INFLUENCE OF CERTAIN STEROIDS ON THE SERUMBILIRUBINCONCENTRATION OF HOMOZYGOUS GUNN-RATS.
VAN LEUSDENH
Bull Soc R Belge Gynecol Obstet; 1964; 34():15-24. PubMed ID: 14185717
[No Abstract] [Full Text] [Related]
16. [A NEW METHOD FOR OVULATION INHIBITION].
HOHENSEE F
Ther Ggw; 1965 Apr; 104():466-70. PubMed ID: 14310694
[No Abstract] [Full Text] [Related]
17. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
18. [Doses-related effects of lynestrenol on ovulation (author's transl)].
Pizarro MA; Thomas K; Ferin J
Reproduccion; 1976; 3(3-4):193-205. PubMed ID: 802117
[TBL] [Abstract][Full Text] [Related]
19. OVULATION INHIBITION BY LYNDIOL: A CLINICAL TRIAL.
TURPEINEN K
Int J Fertil; 1964; 9():137-8. PubMed ID: 14106246
[No Abstract] [Full Text] [Related]
20. Presence of proline in position 3 for potent inhibition of the activity of the luteinizing hormone releasing hormone and of ovulation.
Humphries J; Wan YP; Folkers K; Bowers CY
Biochem Biophys Res Commun; 1976 Oct; 72(3):939-44. PubMed ID: 791291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
